Collagen Synthesis in Tenocytes, Ligament Cells and Chondrocytes Exposed to a Combination of Glucosamine HCl and Chondroitin Sulfate
Open Access
- 25 September 2006
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 4 (2) , 219-224
Abstract
Clinical testing of the nutraceuticals glucosamine (glcN) and chondroitin sulfate (CS) has shown efficacy in providing relief from symptoms in osteoarthritic patients. In vitro and in vivo studies support existence of a synergistic relationship upregulating synthetic activity in chondrocytes. A combination of glcN and CS may also be useful as adjunct therapy in sports‐related injuries if similar upregulation of collagen synthesis is elicited in accessory ligament and tendon joint tissue. Collagen and non‐collagenous protein (NCP) synthesis in cultures of bovine tenocytes, ligament cells and chondrocytes exposed to glcN + CS were assayed by uptake of radiolabeled proline into collagenase‐sensitive material. Assay of radiolabel in hydroxyproline (a specific marker for collagen synthesis) following HPLC isolation confirmed the specificity of the metabolic effect. Synthesis of total collagenase‐sensitive material was maximally upregulated at physiologically obtainable doses of glcN + CS. Tissue response followed the sequence ligament cells (+69%) > chondrocytes (+56%) > tenocytes (+22%). Labeled hydroxyproline increased by 132% in ligament cells, 27% in tenocytes and 49% in epitendon cells after a 48 h exposure to 5 μg ml−1 glcN + 4 μg ml−1 CS. Low dose combinations of glcN and CS effectively stimulate in vitro collagen and NCP synthesis by ligament cells, tenocytes and chondrocytes. Hence, therapeutic use following accessory joint tissue trauma may help augment repair processes.Keywords
This publication has 35 references indexed in Scilit:
- Treatment of Anterior Cruciate Ligament Injuries, Part IThe American Journal of Sports Medicine, 2005
- Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in SportsThe American Journal of Sports Medicine, 2004
- The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogsBiopharmaceutics & Drug Disposition, 2002
- Inhibition of Tendon Cell Proliferation and Matrix Glycosaminoglycan Synthesis by Non-Steroidal Anti-Inflammatory Drugs in vitroJournal of Hand Surgery (European Volume), 2001
- Efficacy of a combination of FCHG49™ glucosamine hydrochloride, TRH122™ low molecular weight sodium chondroitin sulfate and manganese ascorbate* in the management of knee osteoarthritisOsteoarthritis and Cartilage, 2000
- An introduction to the pathophysiology of osteoarthritisFrontiers in Bioscience-Landmark, 1999
- Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clustersOsteoarthritis and Cartilage, 1998
- Identification of the Collagen-Producing Cells in Healing Flexor TendonsPlastic and Reconstructive Surgery, 1989
- Evaluation of the effect of antiarthritic drugs on the secretion of proteoglycans by lapine chondrocytes using a novel assay procedure.Annals of the Rheumatic Diseases, 1989
- Modulation and Reexpression of the Chondrocyte Phenotype; Mediation by Cell Shape and Microfilament ModificationPathology and Immunopathology Research, 1988